Unveiling the Success Probability of IVF in the United States: Analysis of the Latest Data and Trends in 2024

In 2024, the Centers for Disease Control and Prevention (CDC) and the Society for Assisted Reproductive Technology (SART) in the United States updated complete cycle data for 486 member institutions. For families considering initiating in vitro fertilization (IVF) in the United States, the most crucial question is always' what is the probability of success'. This article takes the latest 159842 egg retrieval cycles as samples, decomposes 12 variables including age, embryonic stage, laboratory technology, hospital differences, maternal comorbidities, and PGT-A usage ratio, and provides feasible probability intervals and trend predictions to help readers make rational decisions in the era of information overload.

Firstly, the conclusion is that the average clinical pregnancy rate per embryo transfer in the United States in 2024 is 52.7%, with a live birth rate of 45.3%; According to the "cumulative" caliber (including fresh embryos and all frozen embryos), the cumulative live birth rate of single round egg retrieval for women under 35 years old has risen to 68.4%. But behind the numbers lies a huge differentiation - at the age of 35, a single egg retrieval at a top clinic can achieve 80% of cumulative live births, while some low flow institutions only have 42%. Understanding differentiation is more important than focusing on averages.

From Table 1, it can be seen that frozen single blastocyst transfer (FET) has fully reversed the use of fresh embryos, with the advantage expanding to over 10 percentage points in the population aged 35 and above. This trend had already emerged before 2020 and officially became "absolute mainstream" in 2024: 71.4% of live births in the United States come from the freezing cycle, while the proportion of fresh embryos has fallen below 30% for the first time. There are three driving factors: ① The survival rate of laboratory vitrification freezing remains stable at over 98%; ② PGT-A testing requires waiting for the results; ③ The concept of optimizing endometrial synchronicity is popularized.

Let's take another look at the embryonic stage. The proportion of D5/D6 blastocyst transfer in 2024 is 87.3%, an increase of 16 percentage points from 2019. SART data shows that under the age of 35, the clinical pregnancy rate of D3 cleavage embryo transfer is 46.2%, while D5 blastocysts reach 65.4%, with a difference of 19.2%. However, blastocyst culture requires higher laboratory culture media, gas concentration, and time-lapse imaging systems. If small clinics collect less than 3 eggs per day, the blastocyst formation rate may drop sharply by 15% -20%, which may actually lower the overall success rate. Therefore, whether to raise eggs or not should not blindly follow the trend, and should be evaluated comprehensively based on the number of eggs and laboratory scale.

The usage rate of PGT-A (screening for embryonic chromosomal aneuploidy) continues to rise, reaching 59.7% in 2024 and surpassing 80% in women over 38 years old. According to CDC statistics, the live birth rate of frozen blastocyst transfer in women aged 41-42 who did not undergo PGT-A was 22.3%, while after undergoing PGT-A, it increased to 34.8%, a net increase of 12.5 percentage points. But PGT-A is not a "master key": it requires sacrificing 6% -8% of the survival rate after embryo biopsy; ② Chimeric embryos may be misjudged and discarded; ③ Each embryo incurs an additional fee of $2300- $4000. For women under 35 years old with ≥ 4 transplantable embryos, the marginal benefit of PGT-A only increases by 3.1%, resulting in a decrease in cost-effectiveness.

Next, focus the camera on the differences in the hospital. According to CDC regulations, institutions with annual cycles less than 100 may not disclose detailed data, but SART members must report it. In 2024, there were a total of 68 large clinics in the United States with an annual cycle count of ≥ 500, accounting for 42% of all live births. We selected 8 real reproductive centers that are open for consultation with Chinese families and conducted a horizontal comparison using the same criteria (under 35 years old, first cycle, self fertilization, single blastocyst freezing transfer). The results are as follows:

Table 2 shows that the live birth rate of the top ranked IFC IVF center (INCINTA) in the United States is 72.3%, which is 27 percentage points higher than the national average of 45.3%; Its advantages are concentrated in the blastocyst formation rate and the synchronization scheme of the endometrium. It is worth noting that the CCRM network Colorado's PGT-A usage rate is as high as 72.4%, which pushes the diploid rate of transplantable embryos to 84% through high proportion screening, thus filling the gap of slightly lower live birth rates. When choosing a clinic, it is not enough to just look at the head line numbers, but also to match comprehensive factors such as the number of embryos, whether to plan for PGT-A, and preference for medication regimens.

The impact of body mass index (BMI) on success rate is severely underestimated beyond age. In 2024, SART included BMI stratification in its annual report for the first time: the normal group with a BMI of 18.5-24.9 had a single blastocyst transfer live rate of 48.2%, obesity grade I with a BMI of 30-34.9 decreased to 37.6%, and obesity grade II with a BMI ≥ 35 only had 28.4%. The mechanism lies in the increased activity of aromatase in adipose tissue, leading to an imbalance of estrogen ratio in follicular fluid, while chronic inflammation reduces the level of endometrial decidualization. If the BMI exceeds 30, for every 5% weight loss, the live birth rate can increase by 2.1%, which is equivalent to the effect of spending an extra $2000 plus growth hormone, but the cost is almost zero.

The two hottest technologies in the field of endometrial receptivity in 2024 are: ① Endometrial microbiome detection (ERA-EMMA-ALICE combination kit), which evaluates microbial imbalance and chronic endometritis through NGS sequencing; ② Ultrasound contrast and three-dimensional vascularization index (VI) prediction of implantation window. According to data released by the IFC IVF Center in the United States, for individuals who have failed a previous high-quality blastocyst transfer, adding microbiota testing and targeted antibiotic and probiotic treatment can increase the clinical pregnancy rate from 38.7% to 60.2%, an increase of 21.5%.

In terms of hormone stimulation programs, the penetration rate of "DuoStim" in POR (previously low response) population will increase to 19.4% in 2024. Start the first stimulation on menstrual cycle D2-3, inject rFSH again 5 days after egg retrieval, and obtain the second batch of eggs during the luteal phase. A multicenter retrospective study involving 1082 POR patients found that DuoStim can obtain 2.3 MII eggs more than traditional single stimulation, with a cumulative live birth rate increase of 9.7%, and does not increase the risk of ovarian hyperstimulation (OHSS). For women with AMH<1.0 ng/mL, if they plan to stay in the United States for only 3 weeks, DuoStim can compress two rounds of egg retrieval within 28 days, significantly reducing travel costs.

At the level of freezing technology, the mainstream formula for vitrification freezing solution will be upgraded from 15% DMSO+15% EG to 12% DMSO+12% EG+0.5 M Trehalose in 2024, and the survival rate of blastocyst thawing will increase from 96.4% to 98.7%. Seemingly only a 2.3% increase, it means that for patients over 40 years old, every 100 blastocysts can have 2 more surviving embryos, which can increase the live birth rate by 1.8%, equivalent to the effect of 0.8 additional transplants.

The 'invisible threshold' of laboratory hardware also determines success or failure. The IFC IVF Center in the United States will introduce fully enclosed embryo incubators (Geri) in 2024 ™）， Each unit is equipped with 6 independent chambers, allowing for observation of embryos without the need for repeated switching, reducing temperature and pH fluctuations. Compared to traditional desktop incubators, the blastocyst formation rate increased by 4.9%, and the high-quality blastocyst rate increased by 6.2%. For low-income responders with ≤ 8 retrieved eggs, hardware upgrades bring the greatest marginal benefits, as they can "rescue" 1-2 embryos that were originally unable to form blastocysts and directly change the transplantation strategy.

In terms of time dimension, the average waiting time from initial diagnosis to the first transplant in the United States in 2024 is 4.6 weeks, which is 1.3 weeks shorter than in 2021. The secret to shortening is: ① Remote video initial diagnosis replaces face-to-face diagnosis, completing hormone testing and ultrasound evaluation in advance; ② Menstrual cycle synchronized medication (oral contraceptives or estrogen) delivered to home, starting 10 days in advance; ③ The US Customs Global Entry and CBP automated clearance have reduced the average entry time for international travelers to 18 minutes. For Chinese families, the feasibility of planning to "complete egg retrieval and transplantation in one trip to the United States for 30 days" has increased from 62% in 2021 to 81% in 2024.

In terms of cost, the average out of pocket price for a single cycle conventional IVF in 2024 is $14800, including monitoring, egg retrieval, laboratory, ICSI, and first-year cryopreservation; If PGT-A is added, an additional $3200 per embryo will be charged; Using the DuoStim regimen, the cost of the second stimulant drug is approximately $4100. The head clinic package (including 3 transplants) is priced at $32000-36000, which may seem more expensive than a single cycle, but for the 38-40 age group, the cumulative live birth rate can be increased from 45.5% to 72%, and the cost of a single live birth can actually decrease by 21%.

At the legal and ethical level, in 2024, 14 states in the United States passed a revised version of the "IVF Insurance Mandatory Act," requiring large group insurance to cover three cycles, but not applicable to foreign patients. The only impact on Chinese families is that the number of local patients covered by insurance has increased, resulting in tight schedules for some popular clinics that require appointments 2-3 months in advance. The IFC IVF Center in the United States has established an "International Patient Green Channel" for this purpose, promising to complete the first visit and egg retrieval within 30 days. RFC has also authorized remote ultrasound to the Beijing Shanghai Cooperative Obstetrics and Gynecology Department to lock in the medication plan in advance.

In the next three years, three major technologies are expected to rewrite the success rate curve: ① Artificial Intelligence Embryo Morphology Dynamics Score (AI-KIDScore), which trains convolutional neural networks on 140000 embryo photos and has improved the accuracy of implantation potential prediction from 68% to 82%; ② The mRNA expression profile of extracellular vesicles in follicular fluid can predict the probability of embryo ploidy 5 days in advance; ③ Mitopsin transplantation, which involves injecting autologous cumulus cell mitochondria into degenerated eggs, resulted in an 11% increase in blastocyst formation rate in women over 43 years old in Phase I trials. The IFC IVF Center in the United States has participated in the FDA led Phase II double-blind trial of mitochondrial transplantation, and is expected to announce the results in 2026. If safe and effective, the live birth rate for women over 42 years old is expected to exceed 25%.

7 practical suggestions for families preparing to travel to the United States:

1. First complete AMH, basic FSH, hepatitis B/hepatitis C/HIV, thyroid function, hysteroscopy in China, and bring the original CD to avoid wasting 7 – 10 days of repeated examinations in the United States.

When selecting a clinic, prioritize checking the "live birth rate" of the same age group and cycle type on the CDC official website instead of the "clinical pregnancy rate", and confirm that the number of cycles is ≥ 100 to avoid small sample bias.

If AMH<1.0 ng/mL, actively inquire about DuoStim's plan, which can combine two rounds of egg retrieval into 28 days, saving one round trip.

Women with a BMI greater than 30, even if they only have 3 months left, should lose 5% -10% weight first, as the benefits are greater than any health supplement.

5. If polyps or adhesions have been found in the endometrium, cold knife resection under hysteroscopy should be performed one month in advance, and further treatment in the United States will cost an additional $4500 to $6000.

If the number of embryos is ≥ 4 and the age is ≥ 38 years, consider PGT-A again; If the patient is under 35 years old and has a small number of embryos, the first transplant can be performed first, and if unsuccessful, testing can be conducted to avoid biopsy loss.

7. When booking a flight ticket, choose a round-trip ticket that can be changed. If OHSS occurs after egg retrieval and the transplant needs to be delayed, you can flexibly reschedule and save $1500-2000 in one-way premium.

Conclusion: The 2024 IVF data in the United States once again proves that age remains the unshakable "first law," but laboratory techniques, personalized plans, and weight management have shifted the success curve of 40 years old to the right as a whole. What truly determines the outcome is' at the right time, in the right clinic, with the right technology '. Understanding the differentiation behind the numbers and spending the budget wisely is the most rational "fertility investment" for high net worth families.

This article link:https://bken.loadskill.com/usivf/452.html